Explore
Companies
Investors
Top 50
Streams
Trending tech news
Latest investments
Latest acquisitions
Products
Automate
Trackers
Innovation Services
About Index
Index
By TNW
Log in
Register
Dynacure
479
Dynacure
Technology
Biotechnology
Dynacure develops new treatments for serious orphan disorders, such as Centronuclear Myopathies.
Suggest edits
Raised
$55M
Follow us
Companies in the same industry
Tenboron
Probably Genetic
PHITONEX
Zumutor Biologics
MiAlgae
Adaptive Biotechnologies
Cyagen Biosciences
IASO Biotherapeutics
i2o Therapeutics
Biobot Analytics
Alexa global traffic share
Overview
Funding
1
Add info
Latest funding
$55,000,000
Venture capital (Series C) - 2020
Bpifrance
Perceptive Advisors
Tekla Capital Management
+3
Team Size
1–10
Employees
I work here
Location
France
Headquarters
Explore France
$55,000,000
Venture capital (Series C)
Xconomy
Dynacure Adds $55M As RNA-Targeted Muscle Disorder Drug Enters Clinic
